What's Happening?
Sovato, a company specializing in remote robotic telesurgery, has raised $41 million in a Series B funding round led by Beringea. The funding will be used to enhance Sovato's platform, which enables healthcare
organizations to implement scalable and economically sustainable remote surgery programs. The company, based in Santa Barbara, California, aims to make advanced surgical procedures accessible globally. Sovato's platform is system-agnostic, allowing it to integrate with various robotic systems for surgical, interventional, or diagnostic purposes.
Why It's Important?
The expansion of Sovato's platform could revolutionize access to surgical care, particularly in underserved regions where access to skilled surgeons is limited. By enabling remote surgeries, Sovato addresses the growing demand for healthcare services and the shortage of medical professionals. This development could lead to more equitable healthcare delivery, reducing the need for patients to travel long distances for procedures. The investment also highlights the increasing interest in telehealth and robotic surgery as viable solutions to healthcare challenges.
What's Next?
Sovato plans to use the new funding to strengthen partnerships with surgical robotics manufacturers and healthcare providers. The company is also working on establishing global standards for remote robotic surgery, collaborating with leading healthcare institutions to define clinical and operational frameworks. As the global robotic surgery market continues to grow, Sovato's advancements could position it as a leader in this transformative field.
